Not Yet Recruiting
Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors
NCT06652529
- Conditions
- Adenoma, Adnexal Diseases, Bronchial Neoplasms, +38 more
- Locations
-
Not specified